Zobrazeno 1 - 10
of 43
pro vyhledávání: '"Valérie Paris"'
Autor:
Valérie Paris
Publikováno v:
Revue française d'administration publique. :363-384
Cet article presente une revue critique des donnees disponibles pour les comparaisons internationales de l’offre et de l’activite hospitalieres et des depenses associees. Il montre que les differences entre pays resultent a la fois du role joue p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dc6a8ea8b66e5088583c673dd2265212
https://doi.org/10.3917/rfap.174.0067
https://doi.org/10.3917/rfap.174.0067
Autor:
Valérie Paris
Publikováno v:
Les Tribunes de la santé. :47-59
Cet article decrit les mecanismes de financement mobilises dans les pays de l’OCDE pour assurer une couverture sante a leurs residents. La couverture sante de base est le plus souvent garantie par le gouvernement ou l’assurance sociale. L’assur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e0686aa086a38c1d32a8d12cb11375e6
https://doi.org/10.3917/seve1.065.0047
https://doi.org/10.3917/seve1.065.0047
Publikováno v:
OECD Health Working Papers.
With rapid advancements in oncology, even the wealthiest countries around the globe find it increasingly challenging to provide – and sustain – access to new medicines. Challenges include managing the uncertainty surrounding the extent of benefit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f57228f145a7a1cdc082efe55859aafe
https://doi.org/10.1787/4b2e9cb9-en
https://doi.org/10.1787/4b2e9cb9-en
Autor:
Valérie Paris, Martin Wenzl, Brigitte Bloechl-Daum, Guido Rasi, Paul A. Kyrle, Karl Broich, Thomas Senderovitz, Hans-Georg Eichler, Luke Slawomirski, Rui Santos Ivo, Jillian Oderkirk, Ad Schuurman
Publikováno v:
Clinical Pharmacology and Therapeutics
Judicious use of real-world data (RWD) is expected to make all steps in the development and use of pharmaceuticals more effective and efficient, including research and development, regulatory decision making, health technology assessment, pricing, an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0512c6d16a5fbe23e7ee2057245e3c6
http://europepmc.org/articles/PMC6587701
http://europepmc.org/articles/PMC6587701
Autor:
Valérie Paris
Publikováno v:
Bulletin de l'Académie Nationale de Médecine. 202:989-1002
RESUME Cet article presente les defis que pose aux systemes de sante l’arrivee de nombreux medicaments anticancereux, tres onereux, parfois pour des benefices cliniques mineurs. Il montre que les pratiques de prix pour ces produits rendent inoperan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a53ee796dc16169300ee5596ade62386
https://doi.org/10.1016/s0001-4079(19)30264-x
https://doi.org/10.1016/s0001-4079(19)30264-x
Autor:
Valérie Paris, David Klemperer, Elliott S. Fisher, Shannon Brownlee, Vikas Saini, Adam G Elshaug, John P. A. Ioannidis, Sandra Garcia-Armesto
Publikováno v:
The Lancet. 390:178-190
Summary The global ubiquity of overuse and underuse of health-care resources and the gravity of resulting harms necessitate an investigation of drivers to inform potential solutions. We describe the network of influences that contribute to poor care
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ec7bc77b771bbe990c54fbfa8e3c7cea
https://doi.org/10.1016/s0140-6736(16)30947-3
https://doi.org/10.1016/s0140-6736(16)30947-3
Autor:
Valérie Paris
Publikováno v:
médecine/sciences. 30:910-915
This paper describes measures adopted by OECD countries in the health sector in response to the economic crisis which began in 2008: increase and diversification of revenues collected for health, increases in user charges, reductions in staff, salari
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a80d14023be710cadb44ef978fab2ce8
https://doi.org/10.1051/medsci/20143010019
https://doi.org/10.1051/medsci/20143010019
Publikováno v:
OECD Health Working Papers.
Universal health coverage has been achieved in nearly all OECD countries, providing the population with access to a defined range of goods and services. This paper provides detailed descriptions of how countries delineate the range of benefits covere
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1d6c56a84ced5fd141156074eb5359c8
https://doi.org/10.1787/5jlnb59ll80x-en
https://doi.org/10.1787/5jlnb59ll80x-en
Publikováno v:
OECD Health Working Papers.
This paper provides a detailed description of health coverage in OECD countries in 2012. It includes information on the organisation of health coverage (residence-based vs contributory systems), on the range of benefits covered by basic health covera
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::486f96e7b6f73d859d486cf67f2ceaf5
https://doi.org/10.1787/5jlz3kbf7pzv-en
https://doi.org/10.1787/5jlz3kbf7pzv-en
Publikováno v:
OECD Health Working Papers.
Across OECD countries, pharmaceutical spending reached around USD 800 billion in 2013, accounting for about 20% of total health spending on average when pharmaceutical consumption in hospital is added to the purchase of pharmaceutical drugs in the re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b32c6191c0850af30011ec92f0582b90
https://doi.org/10.1787/5jm0q1f4cdq7-en
https://doi.org/10.1787/5jm0q1f4cdq7-en